Dario Marino

7PUBLICATIONS
58CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMedical parasitologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 04, 2026
Role of direct-acting antivirals in people with HIV-associated non-Hodgkin lymphoma and concomitant HCV infection: A study on behalf of the Fondazione Italiana Linfomi.

|Aug 31, 2026
Survival after first relapse in marginal zone lymphomas: Prospective data from the international observational NF10 study.

|Feb 24, 2024
Kaposi's Sarcoma: Evaluation of Clinical Features, Treatment Outcomes, and Prognosis in a Single-Center Retrospective Case Series.

Irene Russo, Dario Marino, Claudia Cozzolino

|Jan 21, 2022
High ETV6 Levels Support Aggressive B Lymphoma Cell Survival and Predict Poor Outcome in Diffuse Large B-Cell Lymphoma Patients.

Dario Marino, Marco Pizzi, Iuliia Kotova

|Oct 23, 2021
Diagnostic Value of PET/MR with DWI for Burkitt Lymphoma.

Chiara Giraudo, Rossella Simeone, Margherita Fosio

|Aug 26, 2021
RE-MIND: Comparing Tafasitamab + Lenalidomide (L-MIND) with a Real-world Lenalidomide Monotherapy Cohort in Relapsed or Refractory Diffuse Large B-cell Lymphoma.

Pier Luigi Zinzani, Thomas Rodgers, Dario Marino

Pageof 2

Frequent Collaborators

2 joint publications

Marta Coscia

2 joint publications

Luigi Marcheselli

2 joint publications

Michele Spina

2 joint publications

Luca Arcaini